Xtl Biopharma ADR (XTLB)

$0.84 +0.00 (0.06%)
Market Cap 7.51M
Revenue (ttm) 450,000.00
Net Income (ttm) -1.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -228.89%
Debt to Equity Ratio -1.80
Volume 28,537
Avg Vol 853,460
Day's Range N/A - N/A
Shares Out 8.81M
Stochastic %K 12%
Beta 1.16
Analysts Strong Buy
Price Target $6.00

Company Profile

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. The company has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The com...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 3 611 6600
Address:
26 Ben-Gurion St., Ramat Gan, Israel
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 27 at 1:13 PM
$XTLB RSI: 67.02, MACD: 0.0574 Vol: 0.18, MA20: 0.81, MA50: 0.83 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ABnb15
ABnb15 Jan. 22 at 5:39 PM
$XTLB
0 · Reply
Hadaddy1211
Hadaddy1211 Jan. 21 at 5:26 PM
$XTLB why’s nobody talking about this!? Went up almost 60% in a week
1 · Reply
RonBoy3
RonBoy3 Jan. 15 at 1:25 PM
$XTLB See you shorts at the EOD…hey. hey, hey!
0 · Reply
RonBoy3
RonBoy3 Jan. 15 at 12:07 PM
$XTLB Nice way to start the day…!
0 · Reply
Zackpedia
Zackpedia Jan. 14 at 8:02 PM
$XTLB Down to .8
0 · Reply
UgoGreg
UgoGreg Jan. 14 at 5:18 PM
$XTLB https://youtu.be/ygBN8MilTyc
0 · Reply
UgoGreg
UgoGreg Jan. 14 at 5:10 PM
$XTLB https://youtu.be/z_sivgG6Cyg
0 · Reply
Fufat
Fufat Jan. 14 at 3:59 PM
$XTLB Has anyone read their latest filings?
0 · Reply
DEXWireNews
DEXWireNews Jan. 14 at 3:46 PM
$XAIR dropped 21% at Wednesday's open, flirting with $1 support (RSI 65). Meanwhile, $XTLB to acquire 85% of XAIR's NeuroNOS, targeting innovative ASD therapeutics. Despite the dip, XAIR gets a "Strong Buy" with a $11 target from analysts. #stocks #biotech $XAIR
0 · Reply
Latest News on XTLB
XTL Update on Recent Developments

Jan 29, 2026, 4:05 PM EST - 5 days ago

XTL Update on Recent Developments

XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency

Jan 23, 2026, 4:10 PM EST - 11 days ago

XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Jan 13, 2026, 9:28 AM EST - 21 days ago

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Dec 24, 2025, 4:00 PM EST - 5 weeks ago

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

XTL Names Mr. Noam Band as its New Chief Executive Officer

Apr 7, 2025, 9:15 AM EDT - 10 months ago

XTL Names Mr. Noam Band as its New Chief Executive Officer

XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million

Aug 14, 2024, 9:15 AM EDT - 1 year ago

XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million

XTL Entered Definitive Agreement to Acquire The Social Proxy

Jun 5, 2024, 9:15 AM EDT - 1 year ago

XTL Entered Definitive Agreement to Acquire The Social Proxy

XTL To Aquire The Social Proxy

Mar 20, 2024, 10:15 AM EDT - 2 years ago

XTL To Aquire The Social Proxy

XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel

Oct 20, 2023, 4:00 PM EDT - 2 years ago

XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel

XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Oct 20, 2023, 4:00 PM EDT - 2 years ago

XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Dr. Morris C. Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc.'s 2021 Annual Meeting

Sep 20, 2021, 9:05 AM EDT - 4 years ago

Dr. Morris C. Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc.'s 2021 Annual Meeting

OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 27 at 1:13 PM
$XTLB RSI: 67.02, MACD: 0.0574 Vol: 0.18, MA20: 0.81, MA50: 0.83 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ABnb15
ABnb15 Jan. 22 at 5:39 PM
$XTLB
0 · Reply
Hadaddy1211
Hadaddy1211 Jan. 21 at 5:26 PM
$XTLB why’s nobody talking about this!? Went up almost 60% in a week
1 · Reply
RonBoy3
RonBoy3 Jan. 15 at 1:25 PM
$XTLB See you shorts at the EOD…hey. hey, hey!
0 · Reply
RonBoy3
RonBoy3 Jan. 15 at 12:07 PM
$XTLB Nice way to start the day…!
0 · Reply
Zackpedia
Zackpedia Jan. 14 at 8:02 PM
$XTLB Down to .8
0 · Reply
UgoGreg
UgoGreg Jan. 14 at 5:18 PM
$XTLB https://youtu.be/ygBN8MilTyc
0 · Reply
UgoGreg
UgoGreg Jan. 14 at 5:10 PM
$XTLB https://youtu.be/z_sivgG6Cyg
0 · Reply
Fufat
Fufat Jan. 14 at 3:59 PM
$XTLB Has anyone read their latest filings?
0 · Reply
DEXWireNews
DEXWireNews Jan. 14 at 3:46 PM
$XAIR dropped 21% at Wednesday's open, flirting with $1 support (RSI 65). Meanwhile, $XTLB to acquire 85% of XAIR's NeuroNOS, targeting innovative ASD therapeutics. Despite the dip, XAIR gets a "Strong Buy" with a $11 target from analysts. #stocks #biotech $XAIR
0 · Reply
Wildblitz
Wildblitz Jan. 14 at 2:13 PM
$XTLB Of course it tanks
0 · Reply
LowFloatArmy
LowFloatArmy Jan. 14 at 1:33 PM
$XTLB this is why I stopped holding stocks lol I got stuck here though so let’s goooo!!
0 · Reply
Roadto1mio
Roadto1mio Jan. 14 at 7:47 AM
$XAIR $XTLB
0 · Reply
KevMomentum
KevMomentum Jan. 14 at 5:33 AM
$XAIR - “..company disclosed a deal with XTL Biopharmaceuticals Ltd. ($XTLB) to sell 85% of its subsidiary company, NeuroNOS Ltd." The obvious top watch for tomorrow, nearly 60x rvol and closed strong over it's afternoon support range. Eyeing for simple continuation tomorrow on the flip over trend resistance as shown below. No break = no trade, range to $2.75, $3.6+ on the d2 move
0 · Reply
StockScanners
StockScanners Jan. 14 at 2:26 AM
$XTLB keep watch if this holds above .94
0 · Reply
Onpoint456
Onpoint456 Jan. 14 at 1:08 AM
$EVTV $XAIR $AHMA $XTLB $EDBL
0 · Reply
Munna420
Munna420 Jan. 13 at 11:00 PM
$XTLB what a fucking Stuck 😂😂
0 · Reply
topstockalerts
topstockalerts Jan. 13 at 10:45 PM
Top Gainers PT2 $XTLB $IOTR $DCOY $JDZG $BCTX
0 · Reply
Paraboljoker
Paraboljoker Jan. 13 at 10:33 PM
$XTLB
0 · Reply
Munna420
Munna420 Jan. 13 at 10:19 PM
$XTLB Holding for Tomorrow is good or bad option?????
0 · Reply
Professionall
Professionall Jan. 13 at 10:16 PM
$XTLB https://mayafiles.tase.co.il/rpdf/1717001-1718000/P1717124-00.pdf
0 · Reply
prismmarketview
prismmarketview Jan. 13 at 10:02 PM
XTL Biopharmaceuticals $XTLB Acquires Majority Stake in NeuroNOS $XAIR, Pioneering Autism Therapeutics https://prismmarketview.com/xtl-biopharmaceuticals-acquires-majority-stake-in-neuronos-pioneering-autism-therapeutics/
0 · Reply